Literature DB >> 27272485

Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome: Features and Mechanisms.

Mehmet A Topcuoglu1, Aneesh B Singhal2.   

Abstract

BACKGROUND AND
PURPOSE: To compare hemorrhagic and nonhemorrhagic reversible cerebral vasoconstriction syndromes (RCVS) with a view to understand mechanisms.
METHODS: This single-center retrospective study included 162 patients with RCVS. Clinical, brain imaging, and angiography data were analyzed.
RESULTS: The mean age was 44±13 years, 78% women. Hemorrhages occurred in 43% including 21 patients with intracerebral hemorrhage (ICH) and 62 with convexal subarachnoid hemorrhage (cSAH). The frequency of triggers (eg, vasoconstrictive drugs) and risk factors (eg, migraine) were not significantly different between hemorrhagic and nonhemorrhagic RCVS or between subgroups (ICH versus non-ICH, isolated cSAH versus normal scan). Hemorrhagic lesions occurred within the first week, whereas infarcts and vasogenic edema accumulated during 2 to 3 weeks (P<0.001). Although all ICHs occurred before cSAH, their time course was not significantly different (P=0.11). ICH and cSAH occurred earlier than infarcts (P≤0.001), and ICH earlier than vasogenic edema (P=0.009). Angiogram analysis showed more severe vasoconstriction in distal versus proximal segments in all lesion types (ICH, cSAH, infarction, vasogenic edema, and normal scan). The isolated infarction group had more severe proximal vasoconstriction, and those with normal imaging had significantly less vasoconstriction. Multivariable analysis failed to uncover independent predictors of hemorrhagic RCVS; however, female sex predicted ICH (P=0.048), and angiographic severity predicted infarction (P=0.043).
CONCLUSIONS: ICH and cSAH are common complications of RCVS. Triggers and risk factors do not predict lesion subtype but may alter central vasomotor control mechanisms resulting in centripetal angiographic evolution. Early distal vasoconstriction is associated with lobar ICH and cSAH, and delayed proximal vasoconstriction with infarction.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cerebral arterial diseases; headache; stroke; subarachnoid hemorrhage; vasoconstriction

Mesh:

Year:  2016        PMID: 27272485     DOI: 10.1161/STROKEAHA.116.013136

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

Review 1.  Risk Factors for Ischemic Stroke in Younger Adults: A Focused Update.

Authors:  Mary G George
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

2.  Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure.

Authors:  Mehmet A Topcuoglu; Ruchira M Jha; Jacob George; Matthew P Frosch; Aneesh B Singhal
Journal:  Neurol Clin Pract       Date:  2017-02

3.  Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Aayushi Garg; Matthew Starr; Marcelo Rocha; Santiago Ortega-Gutierrez
Journal:  Neurology       Date:  2021-05-05       Impact factor: 9.910

Review 4.  Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Authors:  Cecilia Cappelen-Smith; Zeljka Calic; Dennis Cordato
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

Review 5.  Reversible Cerebral Vasoconstriction Syndrome in the Postpartum Period: A Systematic Review and Meta-Analysis.

Authors:  Kimberly Pacheco; Juan Fernando Ortiz; Jashank Parwani; Claudio Cruz; Mario Yépez; Maja Buj; Mahika Khurana; Diego Ojeda; Alisson Iturburu; Alex S Aguirre; Ray Yuen; Shae Datta
Journal:  Neurol Int       Date:  2022-05-31

6.  Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.

Authors:  Aneesh B Singhal; Mehmet A Topcuoglu
Journal:  Neurology       Date:  2016-12-09       Impact factor: 9.910

7.  Dynamic Changes in White Matter Hyperintensities in Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Shih-Pin Chen; Kun-Hsien Chou; Jong-Ling Fuh; Yi-Hua Huang; Chu-Chung Huang; Jiing-Feng Lirng; Yen-Feng Wang; Ching-Po Lin; Shuu-Jiun Wang
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

8.  The Epidemiology of Reversible Cerebral Vasoconstriction Syndrome in Patients at a Colorado Comprehensive Stroke Center.

Authors:  Judd Jensen; Jan Leonard; Kristin Salottolo; Kathryn McCarthy; Jeffrey Wagner; David Bar-Or
Journal:  J Vasc Interv Neurol       Date:  2018-06

9.  Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome.

Authors:  Aayushi Garg; Matthew Starr; Marcelo Rocha; Santiago Ortega-Gutierrez
Journal:  J Neurol       Date:  2021-03-01       Impact factor: 4.849

10.  Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus.

Authors:  Naresh Mullaguri; Madihah Hepburn; Christopher Ryan Newey; Premkumar Chandrasekharan Nattanmai
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.